AIP
PCVX icon

Ameritas Investment Partners’s Vaxcyte PCVX Stock Holding History

Ameritas Investment Partners’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Buy
11,960
+1,676
+16% +$91K 0.02% 775
2026
Q1 		$598K Buy
10,284
+990
+11% +$53.7K 0.02% 782
2025
Q4 		$429K Sell
9,294
-271
-3% -$12.1K 0.01% 865
2025
Q3 		$345K Sell
9,565
-3,277
-26% -$109K 0.01% 960
2025
Q2 		$417K Buy
12,842
+280
+2% +$9.18K 0.01% 919
2025
Q1 		$474K Sell
12,562
-206
-2% -$16.5K 0.02% 838
2024
Q4 		$1.05M Buy
12,768
+886
+7% +$88K 0.03% 614
2024
Q3 		$1.36M Buy
11,882
+1,186
+11% +$107K 0.04% 517
2024
Q2 		$808K Buy
10,696
+151
+1% +$10.3K 0.03% 672
2024
Q1 		$720K Buy
10,545
+1,050
+11% +$72.7K 0.02% 711
2023
Q4 		$596K Buy
9,495
+278
+3% +$14.4K 0.02% 754
2023
Q3 		$470K Buy
9,217
+1,625
+21% +$80.2K 0.02% 790
2023
Q2 		$379K Buy
7,592
+1,853
+32% +$87.8K 0.01% 849
2023
Q1 		$215K Hold
5,739
– – 0.01% 1050
2022
Q4 		$258K Buy
5,739
+1,786
+45% +$70.1K 0.01% 995
2022
Q3 		$94K Hold
3,953
– – ﹤0.01% 1532
2022
Q2 		$86K Buy
3,953
+836
+27% +$19.3K ﹤0.01% 1617
2022
Q1 		$75K Hold
3,117
– – ﹤0.01% 1816
2021
Q4 		$74K Hold
3,117
– – ﹤0.01% 1873
2021
Q3 		$79K Hold
3,117
– – ﹤0.01% 1839
2021
Q2 		$70K Buy
3,117
+761
+32% +$15.6K ﹤0.01% 1961
2021
Q1 		$47K Buy
2,356
+804
+52% +$20.2K ﹤0.01% 2123
2020
Q4 		$41K Hold
1,552
– – ﹤0.01% 2094
2020
Q3 		$77K Buy
+1,552
New +$61.8K ﹤0.01% 1588

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Ameritas Investment Partners's PCVX Position: Q2 2026 in Review

Ameritas Investment Partners increased its Vaxcyte (PCVX) stake by 16% in Q2 2026, buying an estimated $91K and bringing the position to 11,960 shares worth $695K. The position accounts for 0.02% of the portfolio, ranked #775.

Ameritas Investment Partners first reported a position in PCVX in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.36M in Q3 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Ameritas Investment Partners held 11,960 shares of Vaxcyte worth $695K as of Q2 2026.
  • Ameritas Investment Partners bought 1,676 Vaxcyte shares in Q2 2026, an estimated $91K.
  • Vaxcyte made up 0.02% of Ameritas Investment Partners's portfolio in Q2 2026, its #775 holding.
  • Ameritas Investment Partners first reported a position in Vaxcyte in Q3 2020 and has held it in 24 quarters since.
  • Ameritas Investment Partners's Vaxcyte position peaked at $1.36M in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.